As of Friday close, Doximity Inc.’s (NYSE:DOCS) stock was down -$0.19, moving down -0.95 percent to $19.89. The average number of shares traded per day over the past five days has been 2,892,640 shares. 1 time new highs have been achieved over the past 5 days, with a -$1.33 fall in that time frame. In the last twenty days, the average volume was 2,524,025, while in the previous 50 days, it was 2,405,240.
Since last month, DOCS stock retreated -16.81%. Shares of the company fell to $19.79 on 09/22/23, the lowest level in the past month. A 52-week high of $40.12 was reached on 02/02/23 after having rallying from a 52-week low of $19.97. Since the beginning of this year, DOCS’s stock price has dropped by -40.73% or -$13.67, and marked a new high 4 times. However, the stock has declined by -50.42% since its 52-week high.
DOCS stock investors should be aware that Doximity Inc. (DOCS) stock had its last reported insider trading activity 8 days ago on Sep 15. Overpeck Craig, the of the company, disposed of 1,000 shares for $21.48 on Sep 15. It resulted in a $21,480 divestment by the insider. Cabral Timothy S sold 4,714 shares at an average price of $34.96 on Jul 28. The insider now owns 10,258 shares following the transaction. On Jul 12, Director Cabral Timothy S sold 7,500 shares at $35.00 apiece. The transaction was valued at $262,500.
Valuation Metrics
Right now, Doximity Inc. (DOCS) has a P/E ratio of about 35.58. The stock’s beta is 1.07. Besides these, the trailing price-to-sales (P/S) ratio of 8.97, the price-to-book (PB) ratio of 3.91, and the price-to-cash flow ratio of 21.02 may also be considered.
Financial Health
In the three months ended June 29, Doximity Inc.’s quick ratio stood at 7.50, while its current ratio was 7.50, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 87.70% percent. In the year ended June 29, EBITDA margin amounted to 32.97%, whereas operating margins totaled 30.50%. Based on annual data, DOCS earned $365.56 million in gross profit and brought in $419.05 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 10.80%. Return on equity (ROE) for the past 12 months was 12.60%.
According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. DOCS’s revenue rose 16.32% to $110.97 million during the quarter, while net income inched up to $108.32 million. While analysts expected Doximity Inc. to report $0.15 quarterly earnings, the actual figure was $0.19 per share, beating the consensus estimate by 26.70%. During the quarter, the company generated $34.66 million in EBITDA. The liabilities of Doximity Inc. were 162.72 million at the end of its most recent quarter ended June 29, and its total debt was $15.63 million. The value of shareholders’ equity is $194.71 million.
Technical Picture
This quick technical analysis looks at Doximity Inc.’s (DOCS) price momentum. With a historical volatility rate of 5.91%, the RSI 9-day stood at 13.03% on 22 September.
With respect to its five-day moving average, the current Doximity Inc. price is down by -6.27% percent or -$1.33. At present, DOCS shares trade -14.67% below its 20-day simple moving average and -44.44% percent below its 100-day simple moving average. However, the stock is currently trading approximately -43.38% below its SMA50 and -43.78% below its SMA200.
Stochastic coefficient K was 1.54% and Stochastic coefficient D was 1.69%, while ATR was 0.69. Given the Stochastic reading of 2.04% for the 14-day period, the RSI (14) reading has been calculated as 19.85%. As of today, the MACD Oscillator reading stands at -0.78, while the 14-day reading stands at -1.70.
Analyst Ratings
Doximity Inc. downgraded its rating on Doximity Inc. (NYSE: DOCS) to a Hold in a note to investors on August 09, 2023. The analysts firm previously had a Buy rating on the stock.Doximity Inc. (DOCS) has been rated Hold by analysts. According to 1 brokerage firm, DOCS is a sell, and 8 firms recommend it is a Hold. There are 1 analyst who say the stock is underweight. A total of 2 analysts rate Doximity Inc. stock as buy, with 3 recommending it as overweight.
With a median target price of $27.00, the current consensus forecast for the stock is $21.00 – $30.00. Based on these forecasts, analysts predict Doximity Inc. (DOCS) will achieve an average price target of $26.60.
